Position in OGN
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$4,468
+$2,493 QoQ
Shares Held
330
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#372
of 626 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 76%
Shared 0%
None 24%
Common Shares in OGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Atlantic Union Bankshares Corp holds $204,844,834 across 16 Drug Manufacturers - General names. OGN ranks #15 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
45,167 | $54,174,657 | |
| 2 | JNJ |
Johnson & Johnson
|
180,687 | $45,889,075 | |
| 3 | ABBV |
AbbVie Inc.
|
135,197 | $34,020,970 | |
| 4 | MRK |
Merck & Co., Inc.
|
145,428 | $18,687,497 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
137,490 | $17,370,485 | |
| 6 | AZN |
Astrazeneca PLC
|
67,255 | $12,752,892 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
135,656 | $7,816,498 | |
| 8 | AMGN |
Amgen Inc
|
17,229 | $6,238,964 |
All Filings in OGN
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,468 | 330 | Shares | Defined | 2026-08-11 | |
| 2026-03-31 | $1,975 | 330 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $3,118 | 435 | Shares | Defined | 2026-02-04 | |
| 2025-09-30 | $5,179 | 485 | Shares | Defined | 2025-11-04 | |
| 2025-06-30 | $1,490 | 154 | Shares | Sole | 2025-08-06 | |
| No filing history on record for this holder in this stock. | ||||||